673PDNab-paclitaxel (Nab) plus gemcitabine (G) is more...

Annals of Oncology 2019 / 10 Vol. 30; Iss. Supplement

673PDNab-paclitaxel (Nab) plus gemcitabine (G) is more effective than G alone in locally advanced, unresectable pancreatic cancer (LAUPC): The GAP trial, a GISCAD phase II comparative randomized trial

Cascinu, S, Berardi, R, Bianco, R, Bilancia, D, Zaniboni, A, Ferrari, D, Mosconi, S, Spallanzani, A, Cavanna, L, Leo, S, Negri, F, Beretta, G D, Sobrero, A, Banzi, M, Morabito, A, Bittoni, A, Marciano
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz247.001
Date:
October, 2019
File:
PDF, 107 KB
2019
Conversion to is in progress
Conversion to is failed